Mielodiszplasztikus szindróma (MDS): vizsgálatok itt: Kína
53 trials · From ClinicalTrials.gov, checked 2026. november 19.. Ask the study team whether a trial fits you.
- No phaseTaking peopleNational Longitudinal Cohort of Hematological Diseases
- Where
- Tianjin
- People
- 2300
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT04645199 - 1. fázisTaking peopleRomiplostim N01 for Platelet Recovery After Haploidentical HSCT
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 130
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07321626 - 1. fázisTaking peopleA Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies
- Where
- Nanchang, Tianjin, Wuhan
- Életkor
- 18 év to 75 év
- People
- 45
- Run by
- Cullgen (Shanghai),Inc
See details and how to joinNCT07347171 - No phaseTaking peopleSafety and Feasibility of Sulforaphane to Promote Early Haematopoietic Recovery After Cord Blood Transplantation
- Where
- Tianjing
- Életkor
- 18 év and over
- People
- 36
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07297576 - No phaseCsak meghívásosFollow-up Study of ICUS and CCUS Patients
- Where
- Suzhou
- Életkor
- 18 év and over
- People
- 300
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT04428489 - No phaseTaking peopleHigh-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
- Where
- Xining
- People
- 1000
- Run by
- Yigeng Cao,MD,PhD
See details and how to joinNCT07205523 - 2. fázisTaking peopleEfficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome Patients
- Where
- Beijin, Chengdu, Jinan, Shijia Zhuang, Zhengzhou
- Életkor
- 18 év and over
- People
- 236
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06918834 - 1. fázisTaking peopleA Study of GLB-001 in Patients With Myeloid Malignancies
- Where
- Beijing, Chongqing, Hangzhou, Hefei, Nanchang, Shanghai, Shenyang, Shijiazhuang, Suzhou, Tianjin, Wenzhou, Wuhan, Zhengzhou
- Életkor
- 18 év and over
- People
- 108
- Run by
- Hangzhou GluBio Pharmaceutical Co., Ltd.
See details and how to joinNCT06378437 - 2. fázisTaking peopleClinical Study of Venetoclax Combined With Azacitidine as Bridging Therapy Prior to Hematopoietic Stem Cell Transplantation in Patients With Higher-Risk Myelodysplastic Syndromes
- Where
- Changchun
- Életkor
- 18 év and over
- People
- 46
- Run by
- Yehui Tan
See details and how to joinNCT07047183 - 2. fázisTaking peopleReduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT
- Where
- Beijing
- Életkor
- 12 év to 65 év
- People
- 40
- Run by
- Peking University People's Hospital
See details and how to joinNCT06984536 - 2. fázisNot yet taking people in KínaReduced Intensity Conditioning for MDS
- Where
- Shanghai
- Életkor
- 14 év to 70 év
- People
- 45
- Run by
- Ruijin Hospital
See details and how to joinNCT07085156 - 2. fázisTaking peopleInterferon-α for TP53 Myeloid Malignancy Post Allo-HSCT
- Where
- Beijing
- Életkor
- 12 év to 65 év
- People
- 35
- Run by
- Peking University People's Hospital
See details and how to joinNCT06130579 - 2/3. fázisTaking peopleMolecular Genetics Guide the Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation
- Where
- Shanghai
- Életkor
- 14 év to 75 év
- People
- 126
- Run by
- Ruijin Hospital
See details and how to joinNCT06972641 - 2. fázisNot yet taking people in KínaSelinexor Combined With Azacitidine Therapy in High-Risk Myeloid Neoplasms Patients
- Where
- Tianjin
- Életkor
- 16 év to 75 év
- People
- 20
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06900088 - 3. fázisTaking peopleRandomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies
- Where
- Fuzhou, Kunming, Nanjin, Nanning, Shanghai, Suzhou, Xiamen
- Életkor
- 16 év to 55 év
- People
- 222
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT05991908 - 3. fázisTaking peopleConditioning Regimen of Melphalan-busulfan and Fludarabine: a Randomized Study of Different Dose of Melphalan
- Where
- Shanghai
- Életkor
- 18 év to 55 év
- People
- 120
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06829472 - 2. fázisTaking peopleA Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 90 worldwide
- Run by
- Akeso
See details and how to joinNCT06196203 - 2. fázisNot yet taking people in KínaSelinexor Combined With Venetoclax Maintenance Therapy After Allo-HSCT
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 73
- Run by
- Ruijin Hospital
See details and how to joinNCT06765928 - 2. fázisTaking peopleProphylactic Intervention for Relapse Prevention Post-Allogeneic Transplantation in Very High-Risk MDS Patients Based on IPSS-M Stratification
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 40
- Run by
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06612944 - 1/2. fázisTaking peopleVA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS
- Where
- Beijing
- Életkor
- 70 év and over
- People
- 54
- Run by
- Navy General Hospital, Beijing
See details and how to joinNCT06471946 - No phaseTaking peopleClinical Registration Study of Haplo-HSCT for Elderly Patients With Acute Leukemia/ Myelodysplastic Syndrome
- Where
- Beijing
- Életkor
- 55 év to 70 év
- People
- 120
- Run by
- Peking University People's Hospital
See details and how to joinNCT05902416 - 1. fázisTaking peopleA Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies
- Where
- Beijing, Chengdu, Harbin, Shanghai, Shijiazhuang, Tianjin
- Életkor
- 18 év and over
- People
- 100
- Run by
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT06550713 - 2. fázisTaking peopleVA Combined With PD-1 Inhibitor for the Treatment of Relapsed and Refractory AML and High-risk MDS
- Where
- Beijing
- Életkor
- 18 év to 70 év
- People
- 67
- Run by
- Beijing 302 Hospital
See details and how to joinNCT06536959 - No phaseTaking peopleIntensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement
- Where
- Shanghai
- Életkor
- 18 év to 55 év
- People
- 50
- Run by
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06111612 - 1/2. fázisTaking peopleTGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 30
- Run by
- Shenzhen TargetRx Co., Ltd.
See details and how to joinNCT06206174